Explore
Suresh Vishnubhatla
General Manager, Chorus
Suresh Vishnubhatla is General Manager of Chorus, X’s moonshot to transform how we make, move and manage the world’s goods.
Suresh has focused his career on rapidly growing businesses by launching innovative products and services. He started his career at Emerson Electric Corp. where he built the Ovation(R) Distributed Control System—a platform for the energy industry that is used to generate power in approximately 60% of the United States and 30% of the world.
Suresh was subsequently a senior executive at BodyMedia (acquired by Jawbone), a pioneer in wearable body monitoring, and Millennium Pharmacy Systems, which led the market in developing and deploying patient side medication management technology for safe pharmaceutical administration, and was a three time recipient of the Inc 500 Fastest Growing Companies award.
Before joining X, Suresh was President of PharMerica Corporation, the second largest provider of pharmaceutical services to the post-acute care, specialty and home infusion markets. PharMerica was acquired by KKR and Walgreens.
He owns several US and international patents and products recognized by national and international publications.
Suresh has focused his career on rapidly growing businesses by launching innovative products and services. He started his career at Emerson Electric Corp. where he built the Ovation(R) Distributed Control System—a platform for the energy industry that is used to generate power in approximately 60% of the United States and 30% of the world.
Suresh was subsequently a senior executive at BodyMedia (acquired by Jawbone), a pioneer in wearable body monitoring, and Millennium Pharmacy Systems, which led the market in developing and deploying patient side medication management technology for safe pharmaceutical administration, and was a three time recipient of the Inc 500 Fastest Growing Companies award.
Before joining X, Suresh was President of PharMerica Corporation, the second largest provider of pharmaceutical services to the post-acute care, specialty and home infusion markets. PharMerica was acquired by KKR and Walgreens.
He owns several US and international patents and products recognized by national and international publications.